台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    28.15
  • 漲跌
    ▼0.05
  • 漲幅
    -0.18%
  • 成交量
    1,609
  • 產業
    上市 生技醫療類股
  • 300人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
神隆 (1789)籌碼相關-宏遠-民生 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

宏遠-民生 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/15227.5000.0027.4521,1110.18%
2024/04/12127.8500.0027.4511,0970.09%
2024/04/11428.1900.0028.0541,0690.37%
2024/04/09127.7000.0027.8019850.10%
2024/03/2900.00128.2527.65-1876-0.11%
2024/03/28127.7500.0027.6518210.12%
2024/03/14226.0000.0026.0025800.34%
2024/03/13325.6500.0025.6535740.52%
2024/01/2400.00225.4025.45-2781-0.26%
2024/01/1600.00526.2226.00-5777-0.64%
2024/01/0300.00226.2026.10-2801-0.25%
2023/12/2800.00326.3026.50-3811-0.37%
2023/12/0100.00126.8526.85-1757-0.13%
2023/11/2700.00126.7526.60-1735-0.14%
2023/11/15126.0500.0026.1517380.14%
2023/11/1400.00325.7025.75-3763-0.39%
2023/11/1000.00225.9525.85-2779-0.26%
2023/11/0600.00326.6026.65-3748-0.40%
2023/11/0200.00226.7026.40-2808-0.25%
2023/10/2000.00325.9025.70-31,160-0.26%
2023/10/1800.00226.9026.40-21,348-0.15%
2023/09/14127.35327.0027.35-22,835-0.07%
2023/09/1300.00127.0027.00-12,887-0.03%
2023/09/1100.00226.7026.75-23,013-0.07%
2023/08/2800.00226.8026.60-23,105-0.06%
2023/08/2500.00226.8026.90-23,100-0.06%
2023/08/2400.00126.8526.85-13,099-0.03%
2023/08/2200.001126.9027.00-113,102-0.35%
2023/08/10129.001129.1729.05-103,039-0.33%
2023/08/0900.001430.8930.75-142,987-0.47%
2023/08/021732.4900.0031.75172,9560.57%
2023/08/01532.41832.6432.70-32,900-0.10%
2023/07/31332.20232.4831.8512,8750.03%
2023/07/28331.3000.0031.7032,8550.11%
2023/07/27231.5300.0031.6022,8470.07%
2023/07/2600.00132.5031.65-12,839-0.04%
2023/07/25132.8000.0032.8012,8500.04%
2023/07/24632.09132.3032.1052,8620.17%
2023/07/21231.6000.0031.5022,8010.07%
2023/07/20831.38131.3031.3072,6860.26%
2023/07/19333.8000.0033.3532,3900.13%
2023/07/183734.551133.7433.70262,2131.17%
2023/07/17230.7000.0033.2521,8910.11%
2023/07/14230.1000.0030.2521,8060.11%
2023/07/12829.0300.0028.9581,8200.44%
2023/07/11629.3300.0029.4561,8590.32%
2023/05/2200.00126.6026.55-11,215-0.08%
2023/05/1900.00126.3526.35-11,214-0.08%
2023/04/1400.00127.2027.00-1931-0.11%
2023/03/21125.65125.8525.7001,8230.00%
2023/03/0700.00226.7026.75-21,995-0.10%
2023/02/2400.000.126.3026.15-0.11,966-0.01%
2023/01/1000.00125.6525.50-11,822-0.05%
2023/01/09125.0000.0025.0011,7970.06%
2022/12/3000.00125.6525.45-11,783-0.06%
2022/12/271026.2700.0026.45101,7230.58%
2022/12/2600.001027.3227.30-101,663-0.60%
2022/12/20126.2000.0025.6511,4910.07%
2022/12/19127.10226.7027.10-11,427-0.07%
2022/12/141126.0500.0026.00111,2770.86%
2022/12/13326.881027.1527.15-71,209-0.58%
2022/12/12126.40726.6026.40-6960-0.62%
2022/11/28123.9000.0024.1011,0500.10%
2022/11/15124.2000.0024.2011,7440.06%
2022/10/211523.9500.0023.30152,1550.70%
2022/10/2000.001524.7024.70-152,333-0.64%
2022/09/20125.5000.0025.5012,8400.04%
2022/09/13127.1000.0027.0012,9220.03%
2022/08/2600.00128.1027.90-12,521-0.04%
2022/08/25227.6000.0028.2022,4710.08%
2022/08/2400.00127.8027.95-12,392-0.04%
2022/08/23126.65127.1527.2002,2870.00%
2022/08/2200.00227.1527.05-22,239-0.09%
2022/08/19426.4500.0026.4042,1390.19%
2022/08/1200.00426.3626.55-41,971-0.20%
2022/07/28326.23125.9025.8021,8250.11%
2022/06/2800.00225.9025.50-21,892-0.11%
2022/06/2400.00125.7025.90-11,835-0.05%
2022/06/17124.8000.0024.8011,5780.06%
2022/04/26125.1000.0024.8511,3100.08%
2022/04/25126.6500.0025.6011,2740.08%
2022/04/2100.001127.8027.40-111,139-0.97%
2022/04/201027.1000.0026.65108811.13%
2022/04/19125.8000.0025.8517450.13%
2021/09/0300.00124.8524.95-1915-0.11%
2021/08/18124.3500.0024.4511,4630.07%
2021/05/0300.003028.8429.55-301,719-1.74%
2021/04/293028.9300.0028.55301,6231.85%
2021/04/0900.002.227.1827.00-2.21,198-0.18%
2021/04/0800.000.126.3526.45-0.11,150-0.01%
2021/04/0700.001026.0026.15-101,144-0.87%
2021/03/1100.00125.9025.80-11,149-0.09%
2021/02/19125.6500.0025.8011,1780.08%
2020/09/23231.80131.9531.5513,9200.03%
2020/09/1800.00132.5032.90-14,468-0.02%
2020/09/1700.00132.9032.30-14,608-0.02%
2020/09/11131.8000.0031.6016,3260.02%
2020/08/28132.6000.0032.5517,7980.01%
2020/07/2900.00931.4931.10-99,959-0.09%
2020/07/28930.7800.0030.80910,1310.09%
2020/07/2300.00232.8532.80-210,104-0.02%
2020/07/2100.00534.0533.45-510,183-0.05%
2020/07/20733.2400.0032.85710,1740.07%
2020/07/1700.00732.8132.75-710,138-0.07%
2020/07/1600.00534.3034.00-510,118-0.05%
2020/07/15134.5000.0033.85110,1140.01%
2020/07/14235.2000.0034.05210,0810.02%
2020/07/13135.3000.0034.95110,0920.01%
2020/07/1000.00235.3035.25-210,081-0.02%
2020/07/06137.1500.0036.6519,7890.01%
2020/07/03437.2000.0037.2049,7210.04%
2020/07/0200.00238.4537.90-29,714-0.02%
2020/07/011237.8300.0038.05129,7450.12%
2020/06/30338.80538.9437.70-29,717-0.02%
2020/06/19139.15139.8539.1508,9050.00%
2020/06/1700.00435.7535.65-47,612-0.05%
2020/06/16135.0000.0034.4517,3280.01%
2020/06/1200.00132.5032.90-16,422-0.02%
2020/06/11233.10233.5031.4506,3560.00%
2020/06/10132.051232.1532.00-116,312-0.17%
2020/06/09231.1000.0031.6026,3700.03%
2020/06/0800.0032.531.7131.30-32.56,571-0.49%
2020/06/03130.0000.0029.9017,5440.01%
2020/06/021629.0300.0029.15167,9000.20%
2020/06/01330.0500.0029.5537,9510.04%
2020/05/27631.6800.0030.9067,9370.08%
2020/05/261033.104534.3232.25-357,837-0.45%
2020/05/2500.00232.2032.90-27,510-0.03%
2020/05/141532.83132.6531.50147,1720.20%
2020/05/13133.051632.8632.90-157,064-0.21%
2020/05/08330.4000.0030.7036,7240.04%
2020/05/0700.00132.3532.40-16,634-0.02%
2020/05/064333.6300.0031.70436,5720.65%
2020/05/0500.00533.4032.10-56,416-0.08%
2020/05/0400.001030.7031.80-106,053-0.17%
2020/04/2100.00328.7328.15-35,648-0.05%
2020/04/2000.00129.4029.40-15,572-0.02%
2020/04/17128.5500.0028.7515,5650.02%
2020/04/16329.63129.9029.1025,5600.04%
2020/04/15128.90129.5528.9005,4810.00%
2020/04/1400.00230.7029.40-25,418-0.04%
2020/04/10128.9000.0029.0015,1810.02%
2020/04/0100.001527.1327.00-154,696-0.32%
2020/03/311526.0700.0026.20154,6050.33%
2020/03/271026.201027.2025.3504,5310.00%
2020/03/26224.802225.1725.80-204,438-0.45%
2020/03/242024.0000.0023.70204,3280.46%
2020/03/1300.00227.1027.20-23,843-0.05%
2020/03/12231.8000.0030.1023,6950.05%
2020/03/11632.60633.0532.3003,4400.00%
2020/03/10634.3800.0033.7563,2040.19%
2020/02/241130.15130.2029.20102,5730.39%
2020/02/12127.95128.1027.9502,6480.00%
2020/02/10127.55128.3027.5502,6100.00%
2020/02/06127.90329.5027.85-22,496-0.08%
2020/01/2000.00227.1527.00-22,184-0.09%
2020/01/13126.85127.1526.8502,1290.00%
2019/12/13126.1000.0025.9511,8990.05%
2019/12/10127.0000.0027.0011,8360.05%
2019/12/06227.60227.8827.6001,8060.00%
2019/12/05127.75128.5027.7501,7860.00%
2019/12/04127.80128.0027.8001,7490.00%
2019/11/29128.70228.8328.70-11,668-0.06%
2019/11/28129.0000.0028.9511,6130.06%
2019/11/27127.60127.9027.6501,4400.00%
2019/11/26227.4500.0027.4521,3890.14%
2019/11/25129.00128.8528.6501,2930.00%
2019/11/22228.85229.0828.8501,2030.00%
2019/11/21629.20627.9729.1001,0700.00%
2019/11/2000.00527.2628.00-5749-0.67%
2019/11/1900.00125.5025.50-1376-0.27%
2019/10/2200.00523.9023.75-5314-1.59%
2019/08/1900.002023.1523.25-20391-5.10%
2019/08/01224.0500.0024.3024060.49%
2019/07/15226.3000.0026.6023630.55%
2019/07/1100.00026.4026.400362-0.01%
2019/04/22126.303.126.2026.15-2.1428-0.49%
2019/04/0900.00126.6026.55-1552-0.18%
2019/04/02126.4500.0026.4015390.19%
2019/03/04327.2500.0027.1035500.55%
2019/02/13227.0500.0027.0026450.31%
2019/01/14327.3500.0027.1036810.44%
2019/01/0900.00327.4527.35-3657-0.46%
2019/01/08127.2500.0027.3016420.16%
2018/11/22126.70127.1026.7006190.00%
2018/10/25523.2500.0022.4055040.99%
2018/08/2700.00631.3531.50-6536-1.12%
2018/08/0800.00532.8032.75-5668-0.75%
2018/05/3100.00133.6534.20-1759-0.13%
2018/05/0800.00131.6031.55-1786-0.13%
2018/05/02132.2500.0032.3518000.12%
2018/04/30332.3000.0032.4038140.37%
2018/03/31134.4500.0034.3519750.10%
2018/03/16533.0800.0033.1559200.54%
2018/01/19535.5300.0035.4551,3300.38%
2018/01/1700.00035.6035.6001,3380.00%
2018/01/16136.9000.0036.0511,3300.08%
2018/01/15136.7000.0036.7011,2970.08%
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
〈神隆法說〉上游原物料漲幅過大 部分產品將啟動漲價Anue鉅亨-2021/05/26
〈神隆法說〉常熟廠代客研製新藥下半年放量 營運可望改善Anue鉅亨-2021/05/26
神隆 相關文章